Zhejiang Doer Biologics Co., Ltd.
Clinical trials sponsored by Zhejiang Doer Biologics Co., Ltd., explained in plain language.
-
New hope for advanced cancer: DR30206 enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called DR30206 in people with advanced or metastatic solid tumors who have run out of standard options. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 216 adults aged 18 to 75 will…
Phase: PHASE1 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New drug combo aims to shrink hard-to-treat gut tumors
Disease control Recruiting nowThis study tests a new drug called DR30206 combined with standard treatments for people with advanced or spreading gastrointestinal cancers. The goal is to see if the combination is safe and can shrink tumors. About 186 adults aged 18 to 75 in China will take part.
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:49 UTC